Loading clinical trials...

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes | Clinical Trials | Clareo Health

RECRUITINGNA

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

Informatics-Based Digital Intervention to Promote Safe Exercise in Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes - A Pilot Efficacy Study

NCT06967701•Yale University

View on ClinicalTrials.gov

Summary

The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This remote participation-based research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently. You do not need to live in Connecticut to participate, as there will be no required in-person visits during the study.

Eligibility

Age

30 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•30-65 years old inclusive
•Diagnosis with type 1 diabetes (T1D) or other insulin deficiency diabetes (latent autoimmune disease of adulthood, diabetes secondary to pancreatitis)
•Less than 1.0 exercise sessions per week
•Smartphone ownership
•English literacy
•Under regular care by a healthcare provider (1+ appointments per year)
•Home Broadband wireless Internet or cell phone network
•Using continuous glucose monitor (CGM) and sharing data with medical record for at least 6 weeks
•Using insulin pump or pen and sharing data with medical record for at least 6 weeks

Exclusion Criteria

•Diabetic ketoacidosis not clearly related to pump site failure in past 6 months
•\>1 episode of severe hypoglycemia (altered mental and/or physical status requiring assistance from another person for recovery) in past 6 months
•A1c ≥10.0%
•Resting blood pressure \>160mmHg systolic or \>100 mmHg diastolic.
•Myocardial infarction or angina in past 12 months
•Uncontrolled arrhythmia (e.g., atrial fibrillation with rapid ventricular response, new onset atrial fibrillation, ventricular tachycardia, escape rhythms)
•Congestive heart failure (stage 3 or 4)
•Exercise-induced asthma (not controlled on inhalers)
•Chronic obstructive pulmonary disease (requiring home oxygen)
•Renal failure
+4 more criteria

Locations (1)

Yale School of Medicine

New Haven, Connecticut, United States

Key Dates

Start Date

July 10, 2025

Primary Completion Date

July 1, 2027

Completion Date

July 1, 2027

Last Updated

November 6, 2025

Enrollment

ESTIMATED participants

Conditions

Type 1 Diabetes (T1D)Latent Autoimmune Diabetes in Adult (LADA)Pancreatitis

Interventions

Exercise program

BEHAVIORAL

Self-monitoring

BEHAVIORAL

Contacts

Yashvi Verma, BS

CONTACT

203-444-0678 activity@yale.edu

Garrett Ash, PhD, CSCS

CONTACT

203-444-3079 garrett.ash@yale.edu

Strategic Timing of Endoscopic Interventions in Infected Necrotizing Pancreatitis

NCT07406698

Pancreatitis, Acute Necrotizing

View study

RECRUITINGNA

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147

Type 1 Diabetes (T1D)Type 2 Diabetes+9 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes

Inclusion Criteria

Exclusion Criteria

Strategic Timing of Endoscopic Interventions in Infected Necrotizing Pancreatitis

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Exercising in Hot Conditions: How Does it Effect Blood Glucose in People With T1D

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis